MEEDER ASSET MANAGEMENT INC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 207 filers reported holding DENALI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$186,000
-13.5%
3,669
+33.6%
0.01%0.0%
Q2 2021$215,000
+54.7%
2,747
+12.5%
0.01%
+42.9%
Q1 2021$139,000
+58.0%
2,441
+0.6%
0.01%
+16.7%
Q3 2020$88,000
+576.9%
2,426
+420.6%
0.01%
+500.0%
Q2 2020$13,000
-50.0%
466
-69.2%
0.00%
-50.0%
Q1 2020$26,000
+271.4%
1,513
+375.8%
0.00%
+100.0%
Q4 2018$7,000
-22.2%
318
-19.9%
0.00%0.0%
Q3 2018$9,0003970.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders